Aamir

Risk stratify significant CAD with 96+% Confidence w the CADScor®System, a point-of-care diagnostic that has CE & FDA clearance.

[Acarix @acarixglobal]

A recent Journal Record article highlights how a CADScor® test led one Oklahoma patient to seek further evaluation, ultimately revealing severe coronary artery disease before significant heart damage occurred.

Stories like this underscore the importance of accessible cardiac assessment and earlier detection.

Read the full article: https://t.co/ROMGLUhwju

#Acarix #CADScor #Cardiology #CoronaryArteryDisease #MedTech #HeartHealth

[Acarix @acarixglobal]

Early cardiac assessment is about reducing uncertainty.

The CADScor® System helps support informed decision-making at the point of care.

#Cardiology #CADScorSystem

https://t.co/ERtuhNJ9OW

[Acarix @acarixglobal]

For patients, uncertainty is often the hardest part.

Chest pain can lead to multiple visits and delayed answers.

That’s where concern turns into a search for answers.
The CADScor® System helps bring more direction.

https://t.co/lVn6rCgDzH

#PatientExperience #HeartHealth

[Acarix @acarixglobal]

Heart health is shaped over time.

New research shows lifestyle even exercise timing can influence risk.

The first step often determines the rest. The CADScor® System helps inform those early decisions.

https://t.co/rUyJGwFTjk

#HeartHealth #Prevention #CADScorSystem

[Acarix @acarixglobal]

Progress in cardiovascular care is real. So is the
work ahead.

Risk factors like hypertension, diabetes and obesity
remain widespread, and CAD prevalence began
rising again in 2019.

CADScor® System supports earlier cardiac assessment
with a non-invasive approach designed for real-world clinical settings. Learn more.

https://t.co/NvILwnBUuF

#HeartHealth #CADScorSystem #CardiovascularCare

[The Oklahoman @TheOklahoman_]

New heart disease detector could save billions, improve care in Oklahoma https://t.co/7Tc0lCTymO

[Acarix @acarixglobal]

Day 1 at #ACC26 is underway with strong engagement across sessions.

Our UC Davis collaboration abstract was presented today by Dr. Surabhi Atreja and Dr. Pushkal J., highlighting the CADScor® System as a non-invasive, point-of-care aid in chest pain assessment.

Acarix will be onsite throughout the conference. Visit Booth 1811.

#Cardiology #PointOfCare #ChestPain #HealthcareInnovation

[Acarix @acarixglobal]

Chest pain or shortness of breath can raise important questions.

The CADScor® System assist with point of care to help assess symptomatic patients suspected of stable coronary artery disease.

Learn more about Acarix’s evidence-based approach to earlier cardiac assessment.

https://t.co/HEmdQTCKOm

#HeartHealth #CardiovascularCare #CADScorSystem

[Acarix @acarixglobal]

Acarix will be at @ArchSymposium 2026.

The ARCH consortium brings together cardiology leaders from around the world to advance cardiovascular care. Looking forward to connecting in St. Louis.

https://t.co/8f88bCj5xe

#ARCH2026 #Cardiology #MedTech #CardiologyInnovation

[Acarix @acarixglobal]

Our abstract, developed in collaboration with UC Davis, is being presented by Dr. Surabhi Atreja at the American College of Cardiology’s 75th Annual Scientific Session & Expo (#ACC26).

The study evaluates the CADScor® System as a first-line diagnostic aid in chest pain patients, demonstrating high NPV and potential for lower resource utilization.

Join the session: March 28, 3:30–4:30 PM

https://t.co/BV09L0uqfj

#ACC26 #Cardiology

[Acarix @acarixglobal]

When someone feels something “off” in their chest, the hardest part is often the uncertainty.
Patients don't want unnecessary testing, but they also don't want to miss something important.

Early, non-invasive assessment can help guide next steps with clarity.

https://t.co/HEmdQTDiDU

#HeartHealth #PatientCare #EarlyDetection

[Acarix @acarixglobal]

The heart doesn't speak in one signal.

The #CADScorSystem analyzes multiple acoustic features: blood flow patterns, vessel compliance, and subtle vibrations to create a patient-specific risk score.

It’s a composite picture, built from what the body already tells us.

https://t.co/F221V6umhW

#AcousticAnalysis #CardiacDiagnostics

[Acarix @acarixglobal]

Power doesn't have to be bulky.

The #CADScorSystem is about the size of a smartphone: portable, non-invasive, and designed to fit seamlessly into real-world clinical workflows.

Meaningful diagnostics meets care where it happens.

https://t.co/ERtuhNJHEu

#PointOfCare #MedTech

[Acarix @acarixglobal]

Primary care is often where ambiguity begins.

Having a reliable, non-invasive way to assess cardiac risk guides conversations, referrals, and reassurance, without overburdening patients or pathways.

Curious how the #CADScorSystem fits into your clinic? Schedule a demo.

https://t.co/WTOYiUiWA0

#PrimaryCare #Cardiology

[Acarix @acarixglobal]

Clinical progress isn't about moving faster, it’s about moving smarter.

By identifying low-risk patients earlier, the #CADScorSystem can ease pressure on imaging and specialty services, helping teams focus resources better.

Better use of limited capacity starts early.

https://t.co/F221V6umhW

#CardiacCare #MedTech

[Acarix @acarixglobal]

What would change if escalation wasn’t the default for chest pain evaluations?

The #CADScorSystem enables early, non-invasive coronary risk assessment—supporting more deliberate decisions, fewer avoidable escalations, and better alignment between clinical and operational goals.

https://t.co/wX3o9UGEAX

#MedTech #CardiacCare #HealthSystemStrategy

[Acarix @acarixglobal]

The #CADScorSystem is supported by extensive clinical research and real-world use, giving clinicians data they can stand behind when stratifying risk.

When evidence leads, confidence follows.

https://t.co/MxfhIS1amM

#ClinicalEvidence #HealthcareInnovation

[Acarix @acarixglobal]

The CADScor®System has received EU MDR (2017/745) certification, validating Acarix’s clinical evidence, quality systems, and commitment to patient safety and regulatory excellence.

The certification supports continued and expanded access across Europe and Acarix’s broader global growth strategy.

#EUMDR #MedTech #Cardiology

https://t.co/cNSpsyMzW4

[Acarix @acarixglobal]

February is #HeartMonth: a reminder that heart health is personal. Symptoms aren't always dramatic: on/off discomfort, unexplained fatigue, shortness of breath.

Early cardiac risk assessment helps bring clarity sooner, so patients worry less and move forward with the right next step.

Learn how a CAD Score can offer reassurance:

https://t.co/l6Z5acGy8j

#HeartHealth #PreventiveCare

[Acarix @acarixglobal]

Primary care is where heart questions show up first, often before anything is obvious.

When signs are subtle, the decision is: how concerned should we be?

Acarix is focused on making early cardiac assessment more accessible and actionable, so clinicians can move from gray areas to clearer next steps.

https://t.co/l6Z5acGy8j

#PrimaryCare #Cardiology #PointOfCare